Degnan Chris (CIK 1741968) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-09). Recent activity: Buy URGN (4,483 shares), Sell URGN (2,203 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-09 | UroGen Pharma Ltd. (URGN) | Chief Financial Officer | Buy | 4,483 | $0 |
| 2025-10-09 | UroGen Pharma Ltd. (URGN) | Chief Financial Officer | Sell | 2,203 | $37,121 |
Source: SEC Form 4 filings · as of 2025-10-09